Melinda Lackey - 10 Dec 2021 Form 4 Insider Report for ZIOPHARM ONCOLOGY INC (TCRT)

Role
Senior Vice President, Legal
Signature
/s/ Melinda Lackey
Issuer symbol
TCRT
Transactions as of
10 Dec 2021
Net transactions value
$0
Form type
4
Filing time
13 Dec 2021, 05:06:48 UTC
Previous filing
09 Dec 2021
Next filing
19 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (Right to Buy) Award $0 +370,000 $0.000000 370,000 10 Dec 2021 Common Stock 370,000 $1.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares underlying the options vest on November 29, 2022, and with respect to the remainder, in twelve succesive equal quarterly installments measured from November 29, 2022, subject to the Reporting Person's continued service through each such date.